Deutsche Bank Aktiengesellschaft Cuts CME Group (NASDAQ:CME) Price Target to $167.00

CME Group (NASDAQ:CME) had its price objective decreased by Deutsche Bank Aktiengesellschaft from $181.00 to $167.00 in a research report report published on Thursday, The Fly reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the financial services provider’s stock.

Several other brokerages have also issued reports on CME. Rosenblatt Securities increased their price objective on CME Group from $138.00 to $141.00 and gave the stock a sell rating in a report on Monday, October 5th. Credit Suisse Group increased their price objective on CME Group from $170.00 to $177.00 and gave the stock a neutral rating in a report on Thursday, September 10th. Oppenheimer reiterated a buy rating on shares of CME Group in a report on Wednesday, July 29th. Zacks Investment Research upgraded CME Group from a sell rating to a hold rating and set a $175.00 price objective for the company in a report on Tuesday, September 29th. Finally, Wells Fargo & Company cut their price objective on CME Group from $186.00 to $176.00 in a report on Monday, July 6th. Five equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. The stock has a consensus rating of Hold and an average price target of $182.29.

Shares of CME Group stock traded down $0.75 during midday trading on Thursday, hitting $149.24. The company’s stock had a trading volume of 48,354 shares, compared to its average volume of 1,958,426. The firm has a market capitalization of $53.79 billion, a P/E ratio of 22.62, a PEG ratio of 5.09 and a beta of 0.32. The stock has a 50-day simple moving average of $166.35 and a 200-day simple moving average of $172.99. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group has a 1-year low of $131.80 and a 1-year high of $225.36.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 28th. The financial services provider reported $1.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.41 by ($0.03). CME Group had a return on equity of 9.93% and a net margin of 46.39%. During the same period in the previous year, the business earned $1.90 EPS. As a group, sell-side analysts predict that CME Group will post 6.87 earnings per share for the current year.

In related news, Director Daniel R. Glickman sold 900 shares of CME Group stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $173.22, for a total transaction of $155,898.00. Following the sale, the director now directly owns 14,405 shares of the company’s stock, valued at $2,495,234.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Charles P. Carey sold 8,000 shares of CME Group stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $165.39, for a total value of $1,323,120.00. Over the last ninety days, insiders sold 15,900 shares of company stock worth $2,695,838. 1.20% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the stock. Private Vista LLC grew its position in CME Group by 2.3% during the second quarter. Private Vista LLC now owns 2,834 shares of the financial services provider’s stock worth $461,000 after buying an additional 65 shares in the last quarter. CWM LLC boosted its holdings in CME Group by 2.4% during the third quarter. CWM LLC now owns 2,893 shares of the financial services provider’s stock valued at $484,000 after purchasing an additional 67 shares in the last quarter. Buckley Wealth Management LLC boosted its holdings in CME Group by 4.0% during the second quarter. Buckley Wealth Management LLC now owns 1,789 shares of the financial services provider’s stock valued at $291,000 after purchasing an additional 68 shares in the last quarter. Coe Capital Management LLC boosted its holdings in CME Group by 0.6% during the second quarter. Coe Capital Management LLC now owns 11,758 shares of the financial services provider’s stock valued at $1,911,000 after purchasing an additional 69 shares in the last quarter. Finally, Ninety One SA PTY Ltd boosted its holdings in CME Group by 0.7% during the second quarter. Ninety One SA PTY Ltd now owns 10,224 shares of the financial services provider’s stock valued at $1,667,000 after purchasing an additional 70 shares in the last quarter. 84.24% of the stock is currently owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Does the Dogs of the Dow strategy work?

The Fly

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.